Inherited Metabolic Disorders - Pipeline Review, H2 2012 New Report
Inherited Metabolic Disorders - Pipeline Review, H2 2012, provides an overview of the Inherited Metabolic Disorders therapeutic pipeline. This report provides information on the therapeutic development for Inherited Metabolic Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inherited Metabolic Disorders. 'Inherited Metabolic Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release